Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones

Clinical trial NCT02503345 · COMPLETED

Trial details

NCT number: NCT02503345
Sponsor: Allena Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Hyperoxaluria Nephrolithiasis Kidney Stones Hyperoxaluria Dietary Hyperoxaluria

Start date: 2015-07-01
Primary completion: 2016-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.